| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.67e-08 | 188 | 69 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | 4.82e-05 | 749 | 69 | 11 | GO:0005509 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF836 ZNF497 ZNF425 ZNF408 NFX1 NFXL1 ZNF398 ZNF202 ZNF205 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 SMAD9 | 1.11e-04 | 1459 | 69 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | structural molecule activity | SLIT2 FRAS1 VWF COL21A1 TNC JAG1 EFEMP2 PAPLN RIMBP2 SSPOP FBN3 | 2.24e-04 | 891 | 69 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | proteoglycan binding | 7.30e-04 | 51 | 69 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | Roundabout binding | 7.60e-04 | 12 | 69 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | RLF ZNF836 ZNF425 ZNF408 NFX1 NFXL1 ZNF398 ZNF202 ZNF205 ZNF227 BCL6 ZNF319 SMAD9 | 9.74e-04 | 1412 | 69 | 13 | GO:0000981 |
| GeneOntologyCellularComponent | extracellular matrix | CCN6 SLIT2 FRAS1 VWF COL21A1 TNC EFEMP2 PAPLN SSPOP F12 FBN3 | 1.08e-05 | 656 | 70 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CCN6 SLIT2 FRAS1 VWF COL21A1 TNC EFEMP2 PAPLN SSPOP F12 FBN3 | 1.11e-05 | 658 | 70 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 6.65e-05 | 530 | 70 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | Weibel-Palade body | 1.64e-04 | 6 | 70 | 2 | GO:0033093 | |
| GeneOntologyCellularComponent | basement membrane | 7.52e-04 | 122 | 70 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | microfibril | 8.42e-04 | 13 | 70 | 2 | GO:0001527 | |
| Domain | Growth_fac_rcpt_ | 7.00e-12 | 156 | 66 | 11 | IPR009030 | |
| Domain | EGF_2 | SLIT2 FAT1 TNC JAG1 EFEMP2 SLIT1 WIF1 DNER LRP2 SSPOP F12 FBN3 EPHA5 | 7.37e-12 | 265 | 66 | 13 | PS01186 |
| Domain | EGF | 2.08e-11 | 126 | 66 | 10 | PF00008 | |
| Domain | EGF_3 | SLIT2 FAT1 TNC JAG1 EFEMP2 SLIT1 WIF1 DNER LRP2 SSPOP F12 FBN3 | 3.21e-11 | 235 | 66 | 12 | PS50026 |
| Domain | EGF | SLIT2 FRAS1 FAT1 TNC JAG1 EFEMP2 SLIT1 WIF1 DNER LRP2 F12 FBN3 | 3.21e-11 | 235 | 66 | 12 | SM00181 |
| Domain | EGF-like_dom | SLIT2 FRAS1 FAT1 TNC JAG1 EFEMP2 SLIT1 WIF1 DNER LRP2 F12 FBN3 | 6.30e-11 | 249 | 66 | 12 | IPR000742 |
| Domain | EGF_1 | SLIT2 FAT1 TNC JAG1 EFEMP2 SLIT1 WIF1 DNER LRP2 SSPOP F12 FBN3 | 8.30e-11 | 255 | 66 | 12 | PS00022 |
| Domain | EGF-like_CS | SLIT2 FAT1 TNC JAG1 EFEMP2 SLIT1 WIF1 DNER LRP2 F12 FBN3 EPHA5 | 1.09e-10 | 261 | 66 | 12 | IPR013032 |
| Domain | EGF_CA | 4.35e-10 | 122 | 66 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.03e-10 | 124 | 66 | 9 | IPR001881 | |
| Domain | hEGF | 5.47e-10 | 28 | 66 | 6 | PF12661 | |
| Domain | EGF_Ca-bd_CS | 1.77e-09 | 97 | 66 | 8 | IPR018097 | |
| Domain | EGF_CA | 2.08e-09 | 99 | 66 | 8 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.60e-09 | 106 | 66 | 8 | IPR000152 | |
| Domain | CTCK_1 | 3.90e-09 | 18 | 66 | 5 | PS01185 | |
| Domain | Cys_knot_C | 2.38e-08 | 25 | 66 | 5 | IPR006207 | |
| Domain | CTCK_2 | 2.38e-08 | 25 | 66 | 5 | PS01225 | |
| Domain | ASX_HYDROXYL | 6.13e-08 | 100 | 66 | 7 | PS00010 | |
| Domain | - | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 8.29e-08 | 679 | 66 | 14 | 3.30.160.60 |
| Domain | zf-C2H2 | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 1.07e-07 | 693 | 66 | 14 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 1.08e-07 | 694 | 66 | 14 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 4.15e-07 | 775 | 66 | 14 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 4.29e-07 | 777 | 66 | 14 | PS00028 |
| Domain | VWC_out | 5.30e-07 | 19 | 66 | 4 | SM00215 | |
| Domain | Znf_C2H2-like | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 5.73e-07 | 796 | 66 | 14 | IPR015880 |
| Domain | Znf_C2H2 | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 6.55e-07 | 805 | 66 | 14 | IPR007087 |
| Domain | ZnF_C2H2 | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 6.85e-07 | 808 | 66 | 14 | SM00355 |
| Domain | CT | 9.92e-07 | 22 | 66 | 4 | SM00041 | |
| Domain | EGF_extracell | 2.22e-06 | 60 | 66 | 5 | IPR013111 | |
| Domain | EGF_2 | 2.22e-06 | 60 | 66 | 5 | PF07974 | |
| Domain | Fol_N | 6.82e-06 | 11 | 66 | 3 | IPR003645 | |
| Domain | FOLN | 6.82e-06 | 11 | 66 | 3 | SM00274 | |
| Domain | VWC | 9.59e-06 | 38 | 66 | 4 | SM00214 | |
| Domain | EGF_CA | 1.32e-05 | 86 | 66 | 5 | PF07645 | |
| Domain | VWF_dom | 1.44e-05 | 42 | 66 | 4 | IPR001007 | |
| Domain | TIL_dom | 1.49e-05 | 14 | 66 | 3 | IPR002919 | |
| Domain | ZnF_NFX | 3.68e-05 | 3 | 66 | 2 | SM00438 | |
| Domain | zf-NF-X1 | 3.68e-05 | 3 | 66 | 2 | PF01422 | |
| Domain | Znf_NFX1 | 3.68e-05 | 3 | 66 | 2 | IPR000967 | |
| Domain | Laminin_G | 5.23e-05 | 58 | 66 | 4 | IPR001791 | |
| Domain | cEGF | 1.03e-04 | 26 | 66 | 3 | IPR026823 | |
| Domain | cEGF | 1.03e-04 | 26 | 66 | 3 | PF12662 | |
| Domain | zf-C2H2_6 | 1.18e-04 | 314 | 66 | 7 | PF13912 | |
| Domain | KRAB | 2.64e-04 | 358 | 66 | 7 | PS50805 | |
| Domain | KRAB | 2.64e-04 | 358 | 66 | 7 | PF01352 | |
| Domain | VWFC_1 | 2.77e-04 | 36 | 66 | 3 | PS01208 | |
| Domain | KRAB | 3.18e-04 | 369 | 66 | 7 | SM00349 | |
| Domain | KRAB | 3.23e-04 | 370 | 66 | 7 | IPR001909 | |
| Domain | VWFC_2 | 3.25e-04 | 38 | 66 | 3 | PS50184 | |
| Domain | LAM_G_DOMAIN | 3.25e-04 | 38 | 66 | 3 | PS50025 | |
| Domain | - | 3.56e-04 | 95 | 66 | 4 | 2.60.120.200 | |
| Domain | Laminin_G_2 | 3.79e-04 | 40 | 66 | 3 | PF02210 | |
| Domain | LamG | 5.03e-04 | 44 | 66 | 3 | SM00282 | |
| Domain | TIL | 7.93e-04 | 12 | 66 | 2 | PF01826 | |
| Domain | C8 | 7.93e-04 | 12 | 66 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 9.36e-04 | 13 | 66 | 2 | IPR014853 | |
| Domain | C8 | 9.36e-04 | 13 | 66 | 2 | SM00832 | |
| Domain | VWD | 1.43e-03 | 16 | 66 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.43e-03 | 16 | 66 | 2 | IPR001846 | |
| Domain | VWFD | 1.43e-03 | 16 | 66 | 2 | PS51233 | |
| Domain | SMAD_dom-like | 1.43e-03 | 16 | 66 | 2 | IPR017855 | |
| Domain | - | 1.43e-03 | 16 | 66 | 2 | 2.60.200.10 | |
| Domain | VWD | 1.43e-03 | 16 | 66 | 2 | PF00094 | |
| Domain | TSP_1 | 1.44e-03 | 63 | 66 | 3 | PF00090 | |
| Domain | TSP1 | 1.57e-03 | 65 | 66 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.57e-03 | 65 | 66 | 3 | IPR000884 | |
| Domain | TSP1 | 1.57e-03 | 65 | 66 | 3 | PS50092 | |
| Domain | LH2 | 1.81e-03 | 18 | 66 | 2 | SM00308 | |
| Domain | PLAT | 2.47e-03 | 21 | 66 | 2 | PS50095 | |
| Domain | - | 2.47e-03 | 21 | 66 | 2 | 2.60.60.20 | |
| Domain | PLAT | 2.47e-03 | 21 | 66 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.47e-03 | 21 | 66 | 2 | IPR001024 | |
| Domain | DEATH | 4.08e-03 | 27 | 66 | 2 | SM00005 | |
| Domain | VWC | 4.38e-03 | 28 | 66 | 2 | PF00093 | |
| Domain | LRRCT | 5.70e-03 | 32 | 66 | 2 | PF01463 | |
| Domain | Death | 6.05e-03 | 33 | 66 | 2 | PF00531 | |
| Pubmed | Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. | 1.45e-06 | 11 | 73 | 3 | 22999937 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12515855 | ||
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 4.35e-06 | 2 | 73 | 2 | 12200164 | |
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 4.35e-06 | 2 | 73 | 2 | 10432110 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23320558 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 4.35e-06 | 2 | 73 | 2 | 12097499 | |
| Pubmed | 8.39e-06 | 19 | 73 | 3 | 25691540 | ||
| Pubmed | The transcription factor neurogenin 2 restricts cell migration from the cortex to the striatum. | 9.86e-06 | 20 | 73 | 3 | 11748150 | |
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 9.86e-06 | 20 | 73 | 3 | 29961574 | |
| Pubmed | 1.15e-05 | 21 | 73 | 3 | 16079250 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22315090 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 9813312 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 16840550 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 29282218 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 30898865 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19178938 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 10364234 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 1.30e-05 | 3 | 73 | 2 | 24065825 | |
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 1.30e-05 | 3 | 73 | 2 | 16162649 | |
| Pubmed | A molecular mechanism for the heparan sulfate dependence of slit-robo signaling. | 1.30e-05 | 3 | 73 | 2 | 17062560 | |
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 1.30e-05 | 3 | 73 | 2 | 12141424 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 27788882 | ||
| Pubmed | New neurons follow the flow of cerebrospinal fluid in the adult brain. | 1.30e-05 | 3 | 73 | 2 | 16410488 | |
| Pubmed | Msx genes define a population of mural cell precursors required for head blood vessel maturation. | 1.52e-05 | 23 | 73 | 3 | 21693521 | |
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 1.74e-05 | 24 | 73 | 3 | 26116661 | |
| Pubmed | Contralateral migration of oculomotor neurons is regulated by Slit/Robo signaling. | 2.60e-05 | 4 | 73 | 2 | 27770832 | |
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 2.60e-05 | 4 | 73 | 2 | 16828733 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 19933990 | ||
| Pubmed | Multiple roles for slits in the control of cell migration in the rostral migratory stream. | 2.60e-05 | 4 | 73 | 2 | 14960623 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 10433822 | ||
| Pubmed | 2.77e-05 | 167 | 73 | 5 | 22159717 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 2.80e-05 | 28 | 73 | 3 | 27002738 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 3.02e-05 | 170 | 73 | 5 | 23314748 | |
| Pubmed | 3.82e-05 | 31 | 73 | 3 | 36445780 | ||
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 4.33e-05 | 5 | 73 | 2 | 12954717 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 23636094 | ||
| Pubmed | Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization. | 4.33e-05 | 5 | 73 | 2 | 25894826 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 28234971 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 22000108 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 16885222 | ||
| Pubmed | Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals. | 4.33e-05 | 5 | 73 | 2 | 21118670 | |
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 4.33e-05 | 5 | 73 | 2 | 11748139 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 21864388 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 12609596 | ||
| Pubmed | Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype. | 4.33e-05 | 5 | 73 | 2 | 24043286 | |
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 4.33e-05 | 5 | 73 | 2 | 15207848 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 11520671 | ||
| Pubmed | MIER2 ZNF836 ZC2HC1A ZNF398 ZNF202 ZNF205 KAT6B ZNF710 ZC3HAV1 | 4.85e-05 | 808 | 73 | 9 | 20412781 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 10864954 | ||
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 6.48e-05 | 6 | 73 | 2 | 22306607 | |
| Pubmed | Slit/Robo-mediated chemorepulsion of vagal sensory axons in the fetal gut. | 6.48e-05 | 6 | 73 | 2 | 23161783 | |
| Pubmed | Defective pulmonary vascular remodeling in Smad8 mutant mice. | 6.48e-05 | 6 | 73 | 2 | 19419974 | |
| Pubmed | Robo1 and robo2 control the development of the lateral olfactory tract. | 6.48e-05 | 6 | 73 | 2 | 17360927 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 16439476 | ||
| Pubmed | Pioneer longitudinal axons navigate using floor plate and Slit/Robo signals. | 6.48e-05 | 6 | 73 | 2 | 18842816 | |
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 6.48e-05 | 6 | 73 | 2 | 34249921 | |
| Pubmed | SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. | 6.48e-05 | 6 | 73 | 2 | 18829537 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 26257170 | ||
| Pubmed | In vivo regulation of Bcl6 and T follicular helper cell development. | 6.48e-05 | 6 | 73 | 2 | 20519643 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 11804570 | ||
| Pubmed | Slit antagonizes netrin-1 attractive effects during the migration of inferior olivary neurons. | 6.48e-05 | 6 | 73 | 2 | 12051827 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 18054781 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 38761804 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 28676569 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 18494554 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 21688288 | ||
| Pubmed | Slit molecules prevent entrance of trunk neural crest cells in developing gut. | 9.06e-05 | 7 | 73 | 2 | 25490618 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 20606719 | ||
| Pubmed | 1.14e-04 | 118 | 73 | 4 | 21078624 | ||
| Pubmed | 1.18e-04 | 45 | 73 | 3 | 22696295 | ||
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 23884932 | ||
| Pubmed | Robos and slits control the pathfinding and targeting of mouse olfactory sensory axons. | 1.21e-04 | 8 | 73 | 2 | 18417704 | |
| Pubmed | Motor axons are guided to exit points in the spinal cord by Slit and Netrin signals. | 1.21e-04 | 8 | 73 | 2 | 28986144 | |
| Pubmed | Robo1 and Robo2 cooperate to control the guidance of major axonal tracts in the mammalian forebrain. | 1.21e-04 | 8 | 73 | 2 | 17392456 | |
| Pubmed | Multiple Slits regulate the development of midline glial populations and the corpus callosum. | 1.21e-04 | 8 | 73 | 2 | 22349628 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 1.21e-04 | 8 | 73 | 2 | 25485759 | |
| Pubmed | Slit2 and Robo3 modulate the migration of GnRH-secreting neurons. | 1.21e-04 | 8 | 73 | 2 | 22912413 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 23458899 | ||
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 17581972 | ||
| Pubmed | Conserved roles for Slit and Robo proteins in midline commissural axon guidance. | 1.21e-04 | 8 | 73 | 2 | 15091338 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 15162513 | ||
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 18245384 | ||
| Pubmed | 1.26e-04 | 46 | 73 | 3 | 20301533 | ||
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 12122015 | ||
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 10864955 | ||
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 25056828 | ||
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 22806432 | ||
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 1.55e-04 | 9 | 73 | 2 | 20631173 | |
| Pubmed | A cascade of morphogenic signaling initiated by the meninges controls corpus callosum formation. | 1.62e-04 | 50 | 73 | 3 | 22365545 | |
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 21307234 | ||
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 12642493 | ||
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 37237002 | ||
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 31356769 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.93e-04 | 10 | 73 | 2 | 22973535 | |
| Pubmed | Sex differences in environmental and genetic factors for hypertension. | 1.93e-04 | 10 | 73 | 2 | 18724972 | |
| Pubmed | Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome. | 1.93e-04 | 10 | 73 | 2 | 30046000 | |
| Pubmed | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. | 2.36e-04 | 11 | 73 | 2 | 15875024 | |
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 19509466 | ||
| Pubmed | Molecular mechanisms controlling midline crossing by precerebellar neurons. | 2.36e-04 | 11 | 73 | 2 | 18562598 | |
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 22399681 | ||
| Cytoband | 7q36.1 | 2.31e-04 | 74 | 73 | 3 | 7q36.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | RLF ZNF836 ZNF497 ZNF425 ZNF408 ZNF398 ZNF202 ZNF205 ZNF233 ZNF227 BCL6 ZNF319 ZNF865 ZNF710 | 5.32e-09 | 718 | 50 | 14 | 28 |
| GeneFamily | Neuroblastoma breakpoint family | 3.39e-05 | 23 | 50 | 3 | 662 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 7.69e-04 | 15 | 50 | 2 | 26 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 8.77e-04 | 16 | 50 | 2 | 66 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.79e-10 | 196 | 73 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | CCN6 SLIT2 FRAS1 VWF COL21A1 TNC EFEMP2 SLIT1 PAPLN SSPOP FBN3 | 2.78e-10 | 275 | 73 | 11 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.11e-09 | 191 | 73 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 6.24e-08 | 270 | 73 | 9 | MM17057 | |
| Coexpression | NABA_MATRISOME | CCN6 SLIT2 FRAS1 VWF COL21A1 TNC EFEMP2 SLIT1 WIF1 PAPLN CLEC10A SSPOP F12 FBN3 | 7.78e-07 | 1026 | 73 | 14 | M5889 |
| Coexpression | NABA_MATRISOME | CCN6 SLIT2 FRAS1 VWF TNC EFEMP2 SLIT1 WIF1 PAPLN CLEC10A SSPOP F12 | 2.07e-05 | 1008 | 73 | 12 | MM17056 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.13e-08 | 183 | 73 | 7 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 2.97e-08 | 192 | 73 | 7 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.63e-07 | 188 | 73 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.84e-07 | 189 | 73 | 6 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.84e-07 | 189 | 73 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.27e-07 | 191 | 73 | 6 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.21e-07 | 195 | 73 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.71e-07 | 197 | 73 | 6 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.71e-07 | 197 | 73 | 6 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.51e-07 | 200 | 73 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.51e-07 | 200 | 73 | 6 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.51e-07 | 200 | 73 | 6 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.51e-07 | 200 | 73 | 6 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.10e-06 | 75 | 73 | 4 | 162b69b9934da4623ee378b0e8206c4e4917351b | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Sparc-Astrocyte.Gja1.Sparc-Car2_(Car2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.10e-06 | 75 | 73 | 4 | 98807389b7735b90024ba5e71be60cf95416c077 | |
| ToppCell | Striatum-Macroglia-ASTROCYTE-Gja1-Sparc|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.10e-06 | 75 | 73 | 4 | 15505f3e7a25b3ae51f0917335e92d6279e6d06d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 177 | 73 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 177 | 73 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-05 | 181 | 73 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-05 | 182 | 73 | 5 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 186 | 73 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 187 | 73 | 5 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 1.40e-05 | 187 | 73 | 5 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 188 | 73 | 5 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 188 | 73 | 5 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 189 | 73 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 190 | 73 | 5 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-05 | 190 | 73 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-05 | 191 | 73 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-05 | 191 | 73 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 191 | 73 | 5 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 191 | 73 | 5 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.56e-05 | 191 | 73 | 5 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-05 | 191 | 73 | 5 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 192 | 73 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 192 | 73 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.59e-05 | 192 | 73 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.63e-05 | 193 | 73 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-05 | 194 | 73 | 5 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 197 | 73 | 5 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 197 | 73 | 5 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 197 | 73 | 5 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-05 | 198 | 73 | 5 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-05 | 198 | 73 | 5 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-05 | 198 | 73 | 5 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.89e-05 | 199 | 73 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-05 | 200 | 73 | 5 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-05 | 200 | 73 | 5 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-05 | 200 | 73 | 5 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-05 | 200 | 73 | 5 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 200 | 73 | 5 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-05 | 200 | 73 | 5 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.69e-05 | 105 | 73 | 4 | 76b73bc9236030e0703868fa8f7ecee2affe565b | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.69e-05 | 105 | 73 | 4 | bfd3395c51a0e868aa92eac4e929de59a3fe8b50 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.69e-05 | 105 | 73 | 4 | 96566c83999aa625c84a4ed18a6df9daa99f9578 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.39e-05 | 131 | 73 | 4 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 132 | 73 | 4 | 182973660929fe4174e0354c85863a25518c18c1 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.83e-05 | 138 | 73 | 4 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.27e-05 | 140 | 73 | 4 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-05 | 141 | 73 | 4 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-05 | 141 | 73 | 4 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-05 | 144 | 73 | 4 | cc11cce43d1af8ac63140d05faf215ae9a10cde1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 157 | 73 | 4 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-04 | 157 | 73 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 158 | 73 | 4 | c870fd17213129943562487338e2669e2930d719 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 160 | 73 | 4 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.49e-04 | 163 | 73 | 4 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 165 | 73 | 4 | 15fd9d21dccfa80656a6fa3b72286a6a9252d403 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 165 | 73 | 4 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 167 | 73 | 4 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 167 | 73 | 4 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.67e-04 | 168 | 73 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.91e-04 | 174 | 73 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.91e-04 | 174 | 73 | 4 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 177 | 73 | 4 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| Computational | Blood coagulation factors. | 1.61e-04 | 33 | 35 | 3 | MODULE_131 | |
| Computational | Genes in the cancer module 11. | 2.72e-04 | 540 | 35 | 8 | MODULE_11 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 8.10e-05 | 110 | 61 | 4 | EFO_0803335 | |
| Disease | Malignant neoplasm of salivary gland | 1.12e-04 | 45 | 61 | 3 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 1.28e-04 | 47 | 61 | 3 | C0036095 | |
| Disease | pre-malignant neoplasm (implicated_via_orthology) | 1.50e-04 | 9 | 61 | 2 | DOID:0060071 (implicated_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.54e-04 | 50 | 61 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | breast cancer (is_implicated_in) | 2.67e-04 | 150 | 61 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | hair colour measurement | 2.72e-04 | 615 | 61 | 7 | EFO_0007822 | |
| Disease | leukemia (is_implicated_in) | 3.23e-04 | 13 | 61 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 3.76e-04 | 14 | 61 | 2 | DOID:841 (is_marker_for) | |
| Disease | atrial fibrillation (is_implicated_in) | 3.76e-04 | 14 | 61 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | Proteinuria | 4.34e-04 | 15 | 61 | 2 | HP_0000093 | |
| Disease | dermatomyositis (is_marker_for) | 5.60e-04 | 17 | 61 | 2 | DOID:10223 (is_marker_for) | |
| Disease | Lung diseases | 5.73e-04 | 78 | 61 | 3 | C0024115 | |
| Disease | nephrosis (biomarker_via_orthology) | 9.46e-04 | 22 | 61 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | body weight | 1.08e-03 | 1261 | 61 | 9 | EFO_0004338 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 1.13e-03 | 24 | 61 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.13e-03 | 24 | 61 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.18e-03 | 100 | 61 | 3 | C0010606 | |
| Disease | blood cobalt measurement | 1.21e-03 | 101 | 61 | 3 | EFO_0007577 | |
| Disease | pre-eclampsia (is_implicated_in) | 1.22e-03 | 25 | 61 | 2 | DOID:10591 (is_implicated_in) | |
| Disease | pneumonia (is_marker_for) | 1.53e-03 | 28 | 61 | 2 | DOID:552 (is_marker_for) | |
| Disease | blood nickel measurement | 1.99e-03 | 120 | 61 | 3 | EFO_0007583 | |
| Disease | Lymphoma, Non-Hodgkin | 2.00e-03 | 32 | 61 | 2 | C0024305 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTHCQPTKIGCNHPL | 141 | B0FP48 | |
| VGLGKVHCSCHLPNP | 26 | O76042 | |
| AKLCVPGDQCHGLHP | 211 | O15254 | |
| ALCQAAGHTGPLHKC | 1141 | P12821 | |
| EGKSKCLHHSICPSP | 241 | Q5JQC9 | |
| CLHHSICPSPGNKER | 246 | Q5JQC9 | |
| KASPHIQSCGKCPPH | 311 | P54756 | |
| PHICLHGDCENTKGS | 1246 | Q75N90 | |
| CHKVLEDPLTTPCGH | 21 | Q9UPQ7 | |
| DPPCSALHEHLCLGA | 381 | Q96NA2 | |
| GSSGHPSCLKFCPEL | 241 | Q8WYB5 | |
| LCKEGRCPPVHHGCE | 3781 | Q14517 | |
| PHNCTDCGPSHVLLD | 726 | Q86XX4 | |
| CLGKHEVSPLPCHAV | 641 | Q6ZNB6 | |
| NCGGLDHHAKECSLP | 131 | Q6ZN17 | |
| CHNVKPPVRSCDNGH | 726 | Q13191 | |
| KHPACNLPQDLHGAS | 601 | Q5VYM1 | |
| PCNHLRGKKNPHCAT | 486 | A0A1B0GTH6 | |
| DPQLCRHGPLGKCVH | 126 | Q8TAT6 | |
| CGKPLPCGSLDFIHT | 626 | Q12986 | |
| PGLHTPKCDCAFGTL | 2361 | P98164 | |
| LHSCDPPIIHGNLTC | 191 | Q9UHY1 | |
| CPPDCSHQHRLGLGV | 381 | Q9H237 | |
| GCTPLFIPKLAGSHC | 151 | O95389 | |
| FPGSGVSSQHCPHCL | 371 | Q8N878 | |
| QKPKEPNCHNCGTHI | 31 | P09565 | |
| KEHPGLGSNCCVPLF | 606 | D6RF30 | |
| LHKELCGTEPHGCAS | 61 | I3L3R5 | |
| NPDGITHLQCSCLHP | 271 | Q9H1R2 | |
| NCDHCLSQHGSPGIP | 816 | Q96P44 | |
| KCERCHSILSPGGHA | 31 | Q6Q6R5 | |
| HPPKCTSCGSQSPQH | 471 | P41182 | |
| HCAPLCLLHFGPEGK | 336 | O75342 | |
| LHDCRPSQDCHNLPG | 131 | O95967 | |
| DSNPCHHGGSCLDQP | 586 | Q8NFT8 | |
| TCPAPGLHSEPLSHC | 526 | Q8N344 | |
| PCLLHKGHSECPSGQ | 901 | P78504 | |
| GPHCLCPQHLTGNHC | 116 | P00748 | |
| LKGSELGKQPHCCHG | 726 | O15034 | |
| DTHCQPTKIGCNHPL | 141 | E5RIL1 | |
| HPGCHCPSGMLLLNN | 3121 | A2VEC9 | |
| CSNSHGPCDSIQPHK | 176 | Q3BBV2 | |
| CSNSHGPCDSIQPHK | 211 | Q86T75 | |
| CSNSHGPCDSIQPHK | 211 | Q5TAG4 | |
| CDNGHTCGRPKSLFP | 1386 | Q7Z443 | |
| HGFHPATVCKIPSGC | 366 | O15198 | |
| TSGHVGAPLPCNHIK | 476 | Q9UKU0 | |
| TTQKAHLGHCPHCPS | 126 | Q8IUN9 | |
| NLSHCPIAHSGCAAP | 176 | Q14135 | |
| KIHAGARPHACPDCG | 266 | Q6ZNH5 | |
| IHTGEKPHQCPVCGK | 571 | P0CJ78 | |
| EGCHAHCPPGKILDE | 1171 | P04275 | |
| LGGDPSSNSEKPHCH | 1231 | Q13129 | |
| GLGSSTQHPNKPHCA | 36 | Q7Z6I5 | |
| KPHCALASCQGPGVL | 46 | Q7Z6I5 | |
| GLHHDGQFCHKPCPP | 51 | P25445 | |
| CAIGPPSHCGSLQHS | 511 | O95428 | |
| PPVGEQVFSCHHCGK | 336 | Q8TD17 | |
| HTGEAHLCPVCGKAL | 546 | Q9H9D4 | |
| CGKPTCPHACHTQGR | 341 | P24821 | |
| CGPHGASFLKPCTLT | 166 | Q8IV45 | |
| GHNGIKPHSCPHCSK | 316 | Q8N1W2 | |
| PDGFHGPHCEKALCT | 201 | Q9Y5W5 | |
| VPIHACISNPCKHGG | 956 | O94813 | |
| HSPGNLPKFCHECGT | 291 | Q96GY0 | |
| PKCGVCGHDLAHLSS | 76 | Q9P2F9 | |
| QGTHTGAKPHKCPIC | 411 | O95201 | |
| CLPSHELTHPGEKLC | 356 | A6NK53 | |
| CGKGFSHNSPLICHR | 441 | Q86WZ6 | |
| PGRHPCDCLGQKHKL | 166 | Q15650 | |
| CPLNGSCSKVHFHLP | 521 | Q7Z2W4 | |
| LHCDQPADGPCHGHK | 1371 | O75093 | |
| QHSGKRPFHCPECGR | 351 | Q6IV72 | |
| TKQGSLDPLHHCGTC | 166 | Q5T0J7 | |
| PLLGRHHDCSVCGKS | 391 | O95125 | |
| CFHAEGCGLPPKALH | 856 | Q70J99 | |
| PTGEKPHKCSHCGRT | 716 | Q6ZNA1 | |
| HAGPSCVGSAKLIPH | 241 | Q8N8K9 |